OrbiMed Advisors is part of a partnership interested in acquiring all of Kinnate Biopharma. Baker Brothers increased an investment in Madrigal Pharmaceuticals.
Kinnate Biopharma, Madrigal Pharma, and More Stocks See Action From Activist Investors
2023-11-24 23:22
OrbiMed Advisors is part of a partnership interested in acquiring all of Kinnate Biopharma. Baker Brothers increased an investment in Madrigal Pharmaceuticals.
You Might Like...
US-China Climate Deal Builds Momentum for Stronger COP28 Outcome
Dutch regulator rejects Apple’s objections against fines
Divers discover Megalodon teeth in flooded cave in Mexico
US compels Saudi fund to exit Altman-backed AI chip startup - Bloomberg News
RSA ID IQ Report Reveals What You Don’t Know Will Breach You
iPhone 15 hits shelves around the world. Here's what you need to know
AI-Threatened Jobs Are Mostly Held by Women, Study Shows
US Senator Uses ChatGPT for Opening Remarks at a Hearing on AI